Abstract: Pharmaceutical compositions comprising S-(?)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid L-arginine salt, and their use in treatment, control or prevention of bacterial infections is disclosed.
Abstract: Compounds of Formula (I) or a stereoisomer or a pharmaceutically acceptable salt thereof, their preparation, and use in treating a bacterial infection are disclosed.
Abstract: Pharmaceutical compositions comprising ceftibuten or a pharmaceutically acceptable salt thereof, and clavulanic acid or a pharmaceutically acceptable salt thereof are disclosed.
Abstract: Compounds of Formula (I), or a stereoisomer or a pharmaceutically acceptable salt thereof, their preparation, pharmaceutical compositions comprising such compounds and their use in treating and/or preventing bacterial infections are disclosed.
Abstract: Pharmaceutical compositions comprising: (a) at least one cephalosporin antibacterial agent and (b) a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
Abstract: Pharmaceutical compositions comprising: (a) at least one antibacterial agent selected from cefixime, cefpodoxime, ceftibuten, cefuroxime or a pharmaceutically acceptable derivative thereof, and (b) a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
Abstract: The fluid delivery pen of the present invention has a reduced dose setting friction mechanism which may produce a sound of higher audibility for each click corresponding to one unit dose set using a dose setting mechanism and also produces a sound of lower audibility than the former for each click when the set dose is reduced using the dose setting mechanism. The fluid delivery pen driving mechanism of the present invention has an indication to an end of dose of fluid in a cartridge.
Type:
Application
Filed:
March 13, 2015
Publication date:
June 21, 2018
Applicant:
WOCKHARDT LIMITED
Inventors:
Matthew STEPHENSON, Barry KNIGHT, Stephen KNOWLES, Umesh JOSHI, Ashok Tyagi
Abstract: A pharmaceutical compositions comprising: (a) a carbapenem antibacterial agent selected from imipenem, meropenem, ertapenem, doripenem or a pharmaceutically acceptable derivative thereof, and (b) a compound of Formula (I), or a stereoisomer or a pharmaceutical acceptable derivative thereof, are disclosed.
Abstract: Pharmaceutical compositions comprising cefepime or a pharmaceutically acceptable salt thereof, tazobactam or a pharmaceutically acceptable salt thereof, and arginine or a pharmaceutically acceptable salt thereof; and their use in treatment, control or prevention of bacterial infection is disclosed.
Abstract: Pharmaceutical compositions comprising cefepime or a pharmaceutically acceptable salt thereof, tazobactam or a pharmaceutically acceptable salt thereof, and arginine or a pharmaceutically acceptable salt thereof; and their use in treatment, control or prevention of bacterial infection is disclosed.
Abstract: A method for treating bacterial infection using: (a) cefepime or a pharmaceutically acceptable salt thereof, (b) arginine or a pharmaceutically acceptable salt thereof, and (c) tazobactam or a pharmaceutically acceptable salt thereof is disclosed.
Abstract: The methods of treating bacterial infection by administering a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
Abstract: The lyophilized solid pharmaceutical compositions comprising a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
Abstract: The stable pharmaceutical compositions comprising a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
Type:
Application
Filed:
January 12, 2017
Publication date:
February 1, 2018
Applicant:
WOCKHARDT LIMITED
Inventors:
Mohammad Ajmal SHAREEF, Mrutunjaya SAHU, Ajaykumar HANDA
Abstract: Stable pharmaceutical compositions comprising a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.